You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Claims for Patent: 10,213,415

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,213,415

Title:	Compounds as opioid receptor modulators
Abstract:	The invention further relates to methods for preparing such compounds, pharmaceutical compositions containing them, and their use in the treatment of disorders that may be ameliorated or treated by the modulation of opioid receptors.
Inventor(s):	Henry J. Breslin, Chaozhong Cai, Wei He, Robert W. Kavash
Assignee:	Janssen Pharmaceutica NV
Application Number:	US15/616,358
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,213,415
Patent Claims:	1. A method for treating visceral pain in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a compound having the structure: or a pharmaceutically acceptable salt thereof. 2. The method according to claim 1, wherein said compound has the structure: or a pharmaceutically acceptable salt thereof.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.